(A) in the matter preceding clause (i), by 
striking ‘‘to—’’ and inserting ‘‘—’’; 
(B) in clause (i)— 
(i) by striking ‘‘diagnose’’ and insert-
ing ‘‘to diagnose’’; and 
(ii) by striking ‘‘; or’’ and inserting a 
semicolon; 
(C) in clause (ii)— 
(i) by striking ‘‘diagnose’’ and insert-
ing ‘‘to diagnose’’; and 
(ii) by striking the period at the end 
and inserting ‘‘; or’’; and 
(D) by adding at the end the following: 
‘‘(iii) is a product or technology in-
tended to enhance the use or effect of a 
drug, biological product, or device de-
scribed in clause (i) or (ii).’’. 
(2) QUALIFIED PANDEMIC OR EPIDEMIC PROD-
UCT.—Section 319F–3(i)(7)(A) of the Public Health 
Service Act (42 U.S.C. 247d–6d(i)(7)(A)) is amend-
ed— 
(A) in clause (i)(II), by striking ‘‘; or’’ and 
inserting ‘‘;’’; 
(B) in clause (ii), by striking ‘‘; and’’ and 
inserting ‘‘; or’’; and
(C) by adding at the end the following: 
‘‘(iii) a product or technology intended 
to enhance the use or effect of a drug, bio-
logical product, or device described in 
clause (i) or (ii); and’’. 
(3) TECHNICAL AMENDMENTS.—Section 319F– 
3(i) of the Public Health Service Act (42 U.S.C. 
247d–6d(i)) is amended— 
(A) in paragraph (1)(C), by inserting ‘‘, 
564A, or 564B’’ after ‘‘564’’; and 
(B) in paragraph (7)(B)(iii), by inserting 
‘‘, 564A, or 564B’’ after ‘‘564’’. 
SEC. 403. STRATEGIC NATIONAL STOCKPILE. 
Section 319F–2 of the Public Health Service Act (42 
U.S.C. 247d–6b) is amended— 
(1) in subsection (a)— 
(A) in paragraph (1)— 
(i) by inserting ‘‘consistent with sec-
tion 2811’’ before ‘‘by the Secretary to be 
appropriate’’; and 
(ii) by inserting before the period at 
the end of the second sentence the fol-
lowing: ‘‘and shall submit such review an-
nually to the appropriate congressional 
committees of jurisdiction to the extent
that disclosure of such information does 
not compromise national security’’; and 
(B) in paragraph (2)(D), by inserting be-
fore the semicolon at the end the following: 
‘‘and that the potential depletion of counter-
measures currently in the stockpile is identified 
and appropriately addressed, including through 
necessary replenishment’’; and 
(2) 
in 
subsection 
(f)(1), 
by 
striking 
‘‘$640,000,000 for fiscal year 2002, and such sums 
as may be necessary for each of fiscal years 2003 
through 2006. Such authorization is in addition to 
amounts in the special reserve fund referred to in 
subsection (c)(10)(A).’’ and inserting ‘‘$533,800,000 
for each of fiscal years 2013 through 2017. Such 
authorization is in addition to amounts in the special 
reserve fund referred to in subsection (h).’’. 
SEC. 404. NATIONAL BIODEFENSE SCIENCE BOARD. 
Section 319M(a) of the Public Health Service Act (42 
U.S.C. 247d–f(a)) is amended— 
(1) in paragraph (2)— 
(A) in subparagraph (D)— 
(i) in clause (i), by striking ‘‘and’’ at 
the end;
(ii) in clause (ii), by striking the pe-
riod and inserting a semicolon; and 
(iii) by adding at the end the fol-
lowing: 
‘‘(iii) one such member shall be an in-
dividual with pediatric subject matter ex-
pertise; and 
‘‘(iv) one such member shall be a 
State, tribal, territorial, or local public 
health official.’’; and 
(B) by adding at the end the following 
flush sentence: 
‘‘Nothing in this paragraph shall preclude a member 
of the Board from satisfying two or more of the re-
quirements described in subparagraph (D).’’; and 
(2) in paragraph (5)— 
(A) in subparagraph (B), by striking 
‘‘and’’ at the end; 
(B) in subparagraph (C), by striking the 
period and inserting ‘‘; and’’; and 
(C) by adding at the end the following: 
‘‘(D) provide any recommendation, finding, 
or report provided to the Secretary under this
paragraph to the appropriate committees of 
Congress.’’. 
Passed the House of Representatives December 19, 
2012. 
Attest: 
Clerk.